Bone and Heart Abnormalities of Subclinical Hyperthyroidism in Women Below the Age of 65 Years
Overview
Authors
Affiliations
The objective of the present study was to evaluate bone and cardiac abnormalities and symptoms and signs of thyroid hormone excess in women with subclinical hyperthyroidism (SCH) aged < 65 years. Forty-eight women with SCH were evaluated. The control group consisted of 48 euthyroid volunteers. The mean symptom rating scale score was significantly higher in patients. Cardiac involvement, both morphological and affecting systolic and diastolic functions, was also observed in patients. Women with SCH showed a significant increase in serum markers of bone formation and resorption. In addition, bone mineral density (BMD) was lower in the femoral neck but not in the lumbar spine in patients before menopause, whereas a lower BMD was observed at both sites in postmenopausal patients. SCH is not completely asymptomatic in women aged < 65 years, and is associated with heart abnormalities and with increased bone turnover and reduced BMD even before menopause.
Mat Ali M, Tuan Ismail T, Wan Azman W, Yaacob N, Yahaya N, Draman N Diagnostics (Basel). 2020; 10(12).
PMID: 33322284 PMC: 7763871. DOI: 10.3390/diagnostics10121075.
Thyroid Hormone Diseases and Osteoporosis.
Delitala A, Scuteri A, Doria C J Clin Med. 2020; 9(4).
PMID: 32268542 PMC: 7230461. DOI: 10.3390/jcm9041034.
Endogenous subclinical hyperthyroidism may not lead to bone loss in premenopausal women.
Saler T, Ahbab S, Saglam Z, Keskek S, Kurnaz S Hippokratia. 2015; 18(3):240-4.
PMID: 25694759 PMC: 4309145.
The influence of thyroid dysfunction on bone metabolism.
Tuchendler D, Bolanowski M Thyroid Res. 2015; 7(1):12.
PMID: 25648501 PMC: 4314789. DOI: 10.1186/s13044-014-0012-0.
Metabolic and clinical consequences of hyperthyroidism on bone density.
Gorka J, Taylor-Gjevre R, Arnason T Int J Endocrinol. 2013; 2013:638727.
PMID: 23970897 PMC: 3736466. DOI: 10.1155/2013/638727.